Form 8-K - Current report:
SEC Accession No. 0001411690-25-000008
Filing Date
2025-01-27
Accepted
2025-01-27 16:05:39
Documents
18
Period of Report
2025-01-24
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bngo-20250124.htm   iXBRL 8-K 30591
2 EX-3.1 bionano-certificateofamend.htm EX-3.1 19208
3 EX-99.1 bionano-reversesplitpressr.htm EX-99.1 16579
7 image_2.jpg GRAPHIC 45857
8 picture3.jpg GRAPHIC 3015
9 picture4.jpg GRAPHIC 1947
  Complete submission text file 0001411690-25-000008.txt   274503

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20250124.xsd EX-101.SCH 1794
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20250124_lab.xml EX-101.LAB 22532
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20250124_pre.xml EX-101.PRE 13623
20 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20250124_htm.xml XML 2832
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

IRS No.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 25559047
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)